vs
Bioceres Crop Solutions Corp.（BIOX）与Resolute Holdings Management, Inc.（RHLD）财务数据对比。点击上方公司名可切换其他公司
Resolute Holdings Management, Inc.的季度营收约是Bioceres Crop Solutions Corp.的1.5倍（$117.7M vs $77.6M），Resolute Holdings Management, Inc.净利率更高（-1.5% vs -9.6%，领先8.1%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
BIOX vs RHLD — 直观对比
营收规模更大
RHLD
是对方的1.5倍
$77.6M
净利率更高
RHLD
高出8.1%
-9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $117.7M |
| 净利润 | $-7.4M | $-1.7M |
| 毛利率 | 46.8% | 55.7% |
| 营业利润率 | 9.3% | 30.2% |
| 净利率 | -9.6% | -1.5% |
| 营收同比 | -16.8% | — |
| 净利润同比 | -20.2% | — |
| 每股收益（稀释后） | $-0.12 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXRHLD
| Q4 25 | — | $117.7M | ||
| Q3 25 | $77.6M | $120.9M | ||
| Q2 25 | — | $119.6M | ||
| Q1 25 | $60.6M | $103.9M | ||
| Q4 24 | $98.8M | — | ||
| Q3 24 | $93.3M | — | ||
| Q1 24 | $84.0M | — | ||
| Q4 23 | $140.2M | — |
净利润BIOXRHLD
| Q4 25 | — | $-1.7M | ||
| Q3 25 | $-7.4M | $-231.0K | ||
| Q2 25 | — | $-611.0K | ||
| Q1 25 | $-1.6M | $-3.4M | ||
| Q4 24 | $605.2K | — | ||
| Q3 24 | $-6.2M | — | ||
| Q1 24 | $9.8M | — | ||
| Q4 23 | $1.2M | — |
毛利率BIOXRHLD
| Q4 25 | — | 55.7% | ||
| Q3 25 | 46.8% | 59.0% | ||
| Q2 25 | — | 57.5% | ||
| Q1 25 | 39.4% | 52.5% | ||
| Q4 24 | 42.0% | — | ||
| Q3 24 | 40.2% | — | ||
| Q1 24 | 50.8% | — | ||
| Q4 23 | 36.7% | — |
营业利润率BIOXRHLD
| Q4 25 | — | 30.2% | ||
| Q3 25 | 9.3% | 34.3% | ||
| Q2 25 | — | 34.0% | ||
| Q1 25 | 1.5% | 24.7% | ||
| Q4 24 | 14.5% | — | ||
| Q3 24 | 2.5% | — | ||
| Q1 24 | 15.7% | — | ||
| Q4 23 | 12.0% | — |
净利率BIOXRHLD
| Q4 25 | — | -1.5% | ||
| Q3 25 | -9.6% | -0.2% | ||
| Q2 25 | — | -0.5% | ||
| Q1 25 | -2.6% | -3.2% | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | -6.6% | — | ||
| Q1 24 | 11.6% | — | ||
| Q4 23 | 0.9% | — |
每股收益（稀释后）BIOXRHLD
| Q4 25 | — | $-0.20 | ||
| Q3 25 | $-0.12 | $-0.03 | ||
| Q2 25 | — | $-0.07 | ||
| Q1 25 | $-0.02 | $-0.39 | ||
| Q4 24 | $0.00 | — | ||
| Q3 24 | $-0.10 | — | ||
| Q1 24 | $0.14 | — | ||
| Q4 23 | $0.00 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $205.5M |
| 总债务越低越好 | — | $169.8M |
| 股东权益账面价值 | $288.3M | $6.5M |
| 总资产 | $734.9M | $333.4M |
| 负债/权益比越低杠杆越低 | — | 26.03× |
8季度趋势，按日历期对齐
现金及短期投资BIOXRHLD
| Q4 25 | — | $205.5M | ||
| Q3 25 | $15.5M | $148.0M | ||
| Q2 25 | — | $99.9M | ||
| Q1 25 | $38.5M | $71.0M | ||
| Q4 24 | $29.2M | — | ||
| Q3 24 | $32.3M | — | ||
| Q1 24 | $16.4M | — | ||
| Q4 23 | $24.4M | — |
总债务BIOXRHLD
| Q4 25 | — | $169.8M | ||
| Q3 25 | — | $173.4M | ||
| Q2 25 | — | $177.1M | ||
| Q1 25 | — | $180.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
股东权益BIOXRHLD
| Q4 25 | — | $6.5M | ||
| Q3 25 | $288.3M | $10.8M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | $345.0M | $8.9M | ||
| Q4 24 | $346.3M | — | ||
| Q3 24 | $346.0M | — | ||
| Q1 24 | $348.5M | — | ||
| Q4 23 | $335.3M | — |
总资产BIOXRHLD
| Q4 25 | — | $333.4M | ||
| Q3 25 | $734.9M | $293.2M | ||
| Q2 25 | — | $253.3M | ||
| Q1 25 | $798.2M | $214.3M | ||
| Q4 24 | $835.2M | — | ||
| Q3 24 | $827.3M | — | ||
| Q1 24 | $836.1M | — | ||
| Q4 23 | $819.5M | — |
负债/权益比BIOXRHLD
| Q4 25 | — | 26.03× | ||
| Q3 25 | — | 16.01× | ||
| Q2 25 | — | 18.42× | ||
| Q1 25 | — | 20.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $196.1M |
| 自由现金流经营现金流 - 资本支出 | — | $189.2M |
| 自由现金流率自由现金流/营收 | — | 160.8% |
| 资本支出强度资本支出/营收 | — | 5.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $313.2M |
8季度趋势，按日历期对齐
经营现金流BIOXRHLD
| Q4 25 | — | $196.1M | ||
| Q3 25 | $14.4M | $59.6M | ||
| Q2 25 | — | $48.9M | ||
| Q1 25 | $23.3M | $18.4M | ||
| Q4 24 | $-5.4M | — | ||
| Q3 24 | $5.2M | — | ||
| Q1 24 | $-17.4M | — | ||
| Q4 23 | $21.1M | — |
自由现金流BIOXRHLD
| Q4 25 | — | $189.2M | ||
| Q3 25 | — | $58.6M | ||
| Q2 25 | — | $47.5M | ||
| Q1 25 | — | $17.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
自由现金流率BIOXRHLD
| Q4 25 | — | 160.8% | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 39.7% | ||
| Q1 25 | — | 17.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
资本支出强度BIOXRHLD
| Q4 25 | — | 5.8% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | — | 1.2% | ||
| Q1 25 | — | 0.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
现金转化率BIOXRHLD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | — | ||
| Q1 24 | -1.78× | — | ||
| Q4 23 | 17.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
